Colleen A. Brady

2.8k total citations
22 papers, 1.9k citations indexed

About

Colleen A. Brady is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Colleen A. Brady has authored 22 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Colleen A. Brady's work include Cancer-related Molecular Pathways (6 papers), Epigenetics and DNA Methylation (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Colleen A. Brady is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Epigenetics and DNA Methylation (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Colleen A. Brady collaborates with scholars based in United States, Russia and Canada. Colleen A. Brady's co-authors include Laura D. Attardi, Dadi Jiang, Daniela Kenzelmann Brož, Stephano S. Mello, Cynthia M. Otto, Thomas M. Johnson, Kathryn T. Bieging, Rachel L. Dusek, Arend Sidow and Margaret M. Kozak and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Colleen A. Brady

21 papers receiving 1.8k citations

Peers

Countries citing papers authored by Colleen A. Brady

Since Specialization

Citations

This map shows the geographic impact of Colleen A. Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen A. Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen A. Brady more than expected).

Fields of papers citing papers by Colleen A. Brady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen A. Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen A. Brady. The network helps show where Colleen A. Brady may publish in the future.

Co-authorship network of co-authors of Colleen A. Brady

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen A. Brady. A scholar is included among the top collaborators of Colleen A. Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen A. Brady. Colleen A. Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program 2025 ·Cancer Discovery ·Mengxiong Wang, Kathryn Bieging-Rolett, Alyssa M. Kaiser, Colleen A. Brady, (unknown), (unknown), Kha The Nguyen, (unknown), (unknown), (unknown), Nitin Raj, Arielle Elkrief, Sam E. Tischfield, Marc Ladanyi, Michael G. Ozawa, Nam Q. Bui, (unknown), Elsa R. Flores, Laura D. Attardi	0
2	Redefining Engagement with Socio-spatially Marginalised Populations: Learning from Ghana’s Ministry of Inner City and Zongo Development 2019 ·Colleen A. Brady, Michael Hooper	3
3	Fast and accurate HLA typing from short-read next-generation sequence data with xHLA 2017 ·Proceedings of the National Academy of Sciences ·Chao Xie, Zhen Xuan Yeo, Marie Wong, Jason Piper, Tao Long, Ewen F. Kirkness, William Biggs, (unknown), Stephen R. Spellman, Cynthia Vierra‐Green, Colleen A. Brady, Richard H. Scheuermann, Amalio Telenti, (unknown), Suzanne Brewerton, Yaron Turpaz, J. Craig Venter	95
4	Chemical Screening in Zebrafish 2016 ·Methods in molecular biology ·Colleen A. Brady, Andrew J. Rennekamp, Randall T. Peterson	16
5	How transplant centers deal with the dextran shortage: recommendations for comparing alternatives 2016 ·Transfusion ·Colleen A. Brady, Sue Armitage, Brian M. Freed, Merry Duffy, (unknown), (unknown), Joanne Kurtzberg, Donna Regan	4
6	Analysis of p53 Transactivation Domain Mutants Reveals Acad11 as a Metabolic Target Important for p53 Pro-Survival Function 2015 ·Cell Reports ·Dadi Jiang, Edward L. LaGory, Daniela Kenzelmann Brož, Kathryn T. Bieging, Colleen A. Brady, Nichole Link, John Abrams, Amato J. Giaccia, Laura D. Attardi	54
7	Inappropriate p53 activation during development induces features of CHARGE syndrome 2014 ·Nature ·Jeanine L. Van Nostrand, Colleen A. Brady, Heiyoun Jung, Daniel Fuentes, Margaret M. Kozak, Thomas M. Johnson, Chieh‐Yu Lin, Chien-Jung Lin, Donald L. Swiderski, Hannes Vogel, Jonathan A. Bernstein, Tania Attié‐Bitach, Ching-Pin Chang, Joanna Wysocka, Donna M. Martin, Laura D. Attardi	108
8	Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses 2013 ·Genes & Development ·Daniela Kenzelmann Brož, Stephano S. Mello, Kathryn T. Bieging, Dadi Jiang, Rachel L. Dusek, Colleen A. Brady, Arend Sidow, Laura D. Attardi	345
9	Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression 2011 ·Cell ·Colleen A. Brady, Dadi Jiang, Stephano S. Mello, Thomas M. Johnson, Lesley A. Jarvis, Margaret M. Kozak, Daniela Kenzelmann Brož, Shashwati Basak, (unknown), Margaret E. McLaughlin, Anthony N. Karnezis, Laura D. Attardi	422
10	Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood 2011 ·Cytotherapy ·Stephen R. Spellman, Carolyn Katovich Hurley, Colleen A. Brady, (unknown), (unknown), Mary Laughlin, John D. McMannis, Jo-Anna Reems, Donna Regan, Pablo Rubinstein, Joanne Kurtzberg	23
11	Full p53 transcriptional activation potential is dispensable for tumor suppression in diverse lineages 2011 ·Proceedings of the National Academy of Sciences ·Dadi Jiang, Colleen A. Brady, Thomas M. Johnson, Eunice Y. Lee, (unknown), Matthew P. Scott, Laura D. Attardi	68
12	Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood. National Marrow Donor Program Advisory Group 2011 ·Stephen R. Spellman, Carolyn Katovich Hurley, Colleen A. Brady, (unknown), (unknown), (unknown), John D. McMannis, Jo‐Anna Reems, Donna Regan, Pablo Rubinstein, Joanne Kurtzberg	1
13	p53 at a glance 2010 ·Journal of Cell Science ·Colleen A. Brady, Laura D. Attardi	287
14	Association of hyponatremia and hyperglycemia with outcome in dogs with congestive heart failure 2004 ·Journal of Veterinary Emergency and Critical Care ·Colleen A. Brady, Dez Hughes, Kenneth J. Drobatz	28
15	Local and Systemic Complications in a Cat after Poorly Performed Dental Extractions 2004 ·Journal of Veterinary Dentistry ·Alexander M. Reiter, Colleen A. Brady, Colin E. Harvey	12
16	Risk factors, prognostic indicators, and outcome of pyothorax in cats: 80 cases (1986–1999) 2002 ·Journal of the American Veterinary Medical Association ·Lori S. Waddell, Colleen A. Brady, Kenneth J. Drobatz	40
17	Systemic Inflammatory Response Syndrome, Sepsis, and Multiple Organ Dysfunction 2001 ·Veterinary Clinics of North America Small Animal Practice ·Colleen A. Brady, Cynthia M. Otto	79
18	Postoperative Management of the Emergency Surgery Small Animal Patient 2000 ·Veterinary Clinics of North America Small Animal Practice ·Colleen A. Brady, Lesley G. King	8
19	Severe sepsis in cats: 29 cases (1986–1998) 2000 ·Journal of the American Veterinary Medical Association ·Colleen A. Brady, Cynthia M. Otto, Thomas J. Van Winkle, Lesley G. King	126
20	Severe neurologic sequelae in a dog after treatment of hypoadrenal crisis 1999 ·Journal of the American Veterinary Medical Association ·Colleen A. Brady, Charles H. Vite, Kenneth J. Drobatz	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact